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committee – a compulsory requirement and not a matter of the
investigator's choosingFor four decades, a requirement for investigators aiming to conduct
clinical research that involve human subjects has been to submit their
research protocol to an independent ethics committee (EC) for ethical
considerations prior to commencing the study participant recruitment.
Many believe incorrectly that this requirement is based on a declaration
made by the general assembly of the World Medical Association
(WMA) assembled in Helsinki in 1964.1 WMA is the federation of
national medical associations and was established in 1947. This organi-
zation is analogous to the World Dental Federation‐ FDI, which is the
federation of national dental associations. Declarations made by a
majority vote in the general assemblies (GA) of WMA and FDI are not
legally binding under any international legislation and regulations.
Perhaps this is a reason why some clinical investigators seemingly
continue to ignore the requirement for an ethics committee approval
prior to conducting clinical research. This issue of Clinical and
Experimental Research contains a critical appraisal of all systematic
reviews published by the Cochrane collaboration on oral and dental
interventions over the last 5 years. Out of the 960 primary studies
included in the 95 systematic reviews, as many as three out of ten
papers contain no information about any IRB/EC approval.2
Legally binding requirement for an independent ethics committee
approval appeared in the early seventies in several countries, which
includes from 1974 the National Research Act in USA.3 One of the first
publications in the scientific literature on the need for an ethics
committee appear in the inaugural issue of the Journal of Medical Ethics
in April 1975.4 By then, several health care institutions in USA had for
more than 10 years required investigators to seek approval from an
Institutional Review Boards (IRB), albeit for various motives.5 In the
first revision of the text, labeled as the Declaration of Helsinki, a need
for an independent oversight by a research ethics committee was
added as article 2 and the revised version was approved by the
WMA GA in October 1975.6 The initiative prompted more countries
to embark on legislating the requirement on a national basis. The
Council for International Organizations of Medical Sciences (CIOMS)
is a non‐governmental organization (NGO) that had been established
in 1949 by WHO and UNESCO. This body published in 1993 the first
version of the International Ethical Guidelines for Biomedical Research
Involving Human Subjects,7 which has served as a framework for law-
makers on national and international levels. References to several tasks- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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revisions of the document. The European Union established legally
binding standards across national borders in 2001 by the introduction
of directive 2001/20/EC8 that subsequently has been replaced by
regulative EU/No536/2014 introduced in 2014.9 In parallel, WMA
has amended the requirement for, and tasks and qualities of an exter-
nal IRB/EC in the Declaration of Helsinki. Article 23 in the current 7th
revision approved by the WMA GA in 2013 are quite explicit regarding
details and responsibilities of IRB/EC committees,10 which is intriguing
given the lack of a legal foundation of the organization. Obviously,
national regulations takes precedence regarding such details.
Notwithstanding the legal requirement in most countries to require
an approval from an IRC/EC, there are also considerations of minimum
quality standards for clinical research. Several NGOs identify the need
for an external IRB/EC committee approval for clinical research on
humans or animals, e.g., the International Organization for Standardiza-
tion (ISO),11 the International Conference on Harmonization of
Technical Requirements for Registration of Pharmaceuticals for Human
Use (ICH),12 the European Medicines Agency (EMA),13 and in USA the
U.S. Food and Drug Administration (FDA).14 Stated in other words,
clinical research undertaken without prior approval by an IRB/EC can
be considered today as substandard clinical research.
It has been argued that it must be the editors of scientific journals
that should be responsible for assuring that adherence to ethical
standards is being followed. In fact, WMA has declared bluntly in
article 36 of the current version that “Reports of research not in
accordance with the principles of this Declaration should not be accepted
for publication”7. One may interpret in this context that ethical
publishing must be considered as an important element of ethical
clinical research. While the latter was the focus the Declaration of
Helsinki versions two to five, the term “guidelines for ethical reporting”
appeared in the 6th version in 2008.15
The recommendation by WMA to deny publication is actually
stricter than the wording formulated by voluntary medical ethics
organizations such as the International Committee of Medical Journal
Editors (ICOMS) and the World Association of Medical Editors
(WAME). Their respective guidance documents opens for publication
even in lack of an IRB/EC, i.e. “…if no formal ethics committee is
available, a statement indicating that the research was conducted- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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included”,16 alternatively stated “For those investigators who do not have
access to formal ethics review committees, the principles outlined in the
Declaration of Helsinki should be followed”.17 There is no guidance as
to how an editor should proceed to authenticate any claim of inacces-
sibility to a formal IRB/EC. The Committee on Publication Ethics
(COPE) is somewhat more explicit on the need for an independent eth-
ical approval, citing cases on their website where the lack of approval
in a submitted manuscript should raise concerns of proper ethical con-
duct of clinical studies.18 It is likely that the discrepancies of opinion
amongst the voluntary medical editor organizations for the need for
a formal statement in the materials and methods section about ethics
committee approval is reflected in instructions to authors, e.g., within
the fields of oral‐cranio‐maxillofacial‐facial plastic surgery.19
On the other hand, an argument can be made that once an editor
has received a manuscript, the unethical clinical research has already
been conducted and completed. True, a problem getting their research
paper published may be a deterrent for the investigator‐author, but it
is hardly a comfort for the study participant recruited into an unethical
clinical study. Moreover, publishing is today facilitated by a burgeoning
predatory publishing industry that welcome anything from anyone
without much peer‐review scrutiny,20 and it seems like nobody are
able to stop the activity. Perhaps in the future, the main criteria for
differentiating between a predatory and a scholarly publication is
whether there is a statement in the M&M about an IRB/EC.
For this journal, we hope that the section in the instructions to
authors titled “Protection of human subjects and animals in research”
is unambiguous.21 We believe that it is appropriate and in the best
interest of all stakeholders that a statement must be included in the
Methods section of all submitted manuscript indicating that the
protocol and procedures employed were reviewed and approved by
the appropriate IRB/EC.
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